Risk factors for viral reactivation following bone marrow transplantation.
The identification of risk factors for viral reactivation following transplantation is essential in order that antiviral prophylactic regimes may be allocated rationally. In the pretransplant period qualitative serological assessment of recipient and donor is informative with regard to the risk of post-transplant reactivation and disease. In addition, the quantitative level of herpes simplex virus (HSV) IgG in the pretransplant recipient is predictive of post-transplant HSV excretion, although this relationship does not exist for other viruses of the herpes group. We discuss the value of surveillance cultures for cytomegalovirus in the post-transplant period in predicting the development of CMV disease, and how this may allow effective intervention to prevent what is a major cause of morbidity and mortality in the transplant population.
Pillay
D
D
Division of Communicable Diseases, Royal Free Hospital, London, UK.
Webster
A
A
Prentice
H G
HG
Griffiths
P D
PD
D000914:Antibodies, Viral / Q000032:analysis; D016026:Bone Marrow Transplantation; D014645:Herpesvirus 3, Human / Q000254:growth & development / Q000276:immunology; D006801:Humans; D012307:Risk Factors; D018139:Simplexvirus / Q000254:growth & development / Q000276:immunology; D013997:Time Factors; D014775:Virus Activation / Q000502:physiology*
D000914:Antibodies, Viral